Related Experiment Video
Updated: Mar 18, 2026

Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
Published on: July 28, 2016
Characterization of chemical features of potent myeloperoxidase inhibitors
Jalal Soubhye1, Franck Meyer2, Paul Furtmüller3
1Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels, Belgium.
Background:
Despite its important role in the immune system, myeloperoxidase (MPO) is implicated in a wide range of inflammatory syndromes due to its oxidative product HOCl. The oxidative damages caused by MPO make it a new target for developing promising anti-inflammatory agents. In this paper, we tried to understand the mechanism of MPO inhibition in order to facilitate the drug design, to develop more accurate virtual tests and to understand the structure-activity relationship.
Results:
Based on docking experiments, kinetic studies and in vitro tests, it is determined that a potent MPO inhibitor must possess an oxidizable group in addition to a high affinity with the active site. At last, a new hit was found in this work namely 4-(3-hydroxy-phenoxy)-butylamine (5) that has IC50 of 86 nM.
Conclusion:
Hydroxy-phenoxy alkylamine derivatives were found to be promising MPO inhibitors and they may represent an important starting point in the development of more potent MPO inhibitors.
Insights
Researchers identified a new potent inhibitor for myeloperoxidase (MPO), an enzyme linked to inflammation. This discovery aids in designing new anti-inflammatory drugs by understanding MPO inhibition mechanisms.
Area of Science:
- Biochemistry
- Pharmacology
- Immunology
Background:
- Myeloperoxidase (MPO) plays a key role in immunity but also contributes to inflammatory diseases through its oxidative product, hypochlorous acid (HOCl).
- MPO's damaging oxidative effects present it as a therapeutic target for novel anti-inflammatory agents.
Purpose of the Study:
- To elucidate the mechanism of MPO inhibition.
- To guide drug design and improve virtual screening accuracy.
- To understand the structure-activity relationship of MPO inhibitors.
Main Methods:
- Docking experiments
- Kinetic studies
- In vitro assays
Main Results:
- Potent MPO inhibitors require both high affinity for the active site and an oxidizable group.
- A novel MPO inhibitor, 4-(3-hydroxy-phenoxy)-butylamine (5), was identified with an IC50 of 86 nM.
Conclusions:
- Hydroxy-phenoxy alkylamine derivatives show promise as MPO inhibitors.
- These compounds represent a valuable starting point for developing more effective MPO-targeted anti-inflammatory therapies.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
Enzyme Inhibition
Oxidation of Alkenes: Syn Dihydroxylation with Potassium Permanganate
Chemical Agents for Microbial Control

